Clinical trials: Gynaecologic or Digestive Pelvic Cancer
Gynaecologic or Digestive Pelvic Cancer
Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer
Randomised phase 3 trial comparing 2 arms: an experimental treatment (Isolated pelvis perfusion) and a standard treatment (systemic chemotherapy +/- radiotherapy +/- surgery).
- Trial name
- NCT00949039
- Testing
- Isolated pelvis perfusion, radiotherapy, Surgery
- Where
- France
- Volunteers
- 101 people
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris